Private Health in Brazil Market Players Analysis¶
Products and Services¶
This report details the top 10 key players in the private health industry in Brazil, based on the provided data, outlining their main products and services and evaluating available information regarding their volume and revenue.
Hapvida NotreDame Intermédica Resulting from a significant merger, Hapvida NotreDame Intermédica stands as one of the largest health plan operators in the country. Their primary service is offering health plans to a large base of beneficiaries. A key characteristic of their operation is verticalization, meaning they own and operate their hospitals, clinics, and diagnostic centers, aiming to manage costs and improve care coordination through integrated services. As of March 2024, the combined entity served over 8.8 million beneficiaries. Specific consolidated revenue for 2024 was not available, but the overall health plan sector revenue in 2024 was approximately R$ 350 billion.
Grupo NC (includes EMS) Grupo NC is a major Brazilian pharmaceutical conglomerate, with EMS being one of its leading companies. Their main products are a broad portfolio of medicines, covering various therapeutic areas. EMS is notable for leading the market in terms of units sold to pharmacies in Brazil. In 2024, the group achieved a total revenue of R$ 26.4 billion from sales to pharmacies. Volume estimates in terms of units sold were not specified.
Eurofarma Eurofarma is another prominent Brazilian pharmaceutical company known for its significant market growth. They are involved in the production and sale of pharmaceuticals across various therapeutic areas, with operations extending into other Latin American countries. Eurofarma showed strong growth in 2024 and ranked second in sales value to pharmacies in Brazil, following Grupo NC. Specific revenue figures for 2024 from sales to pharmacies were not explicitly stated but were positioned second after Grupo NC's R$ 26.4 billion. Volume estimates were not specified.
Bradesco Saúde Linked to the large Bradesco financial group, Bradesco Saúde is a major health insurance company. Its core service involves providing health insurance plans to corporate and individual clients. They operate primarily through an extensive accredited network of hospitals, clinics, and healthcare professionals nationwide, offering various plan options with differing coverage and reimbursement models. As of March 2024, Bradesco Saúde had 3.81 million beneficiaries. Specific revenue for Bradesco Saúde was not explicitly stated, but the total health plan sector revenue in 2024 was approximately R$ 350 billion.
AMIL ASSISTENCIA MEDICA (Amil) Amil is a significant health plan operator with a strong presence, particularly in major urban centers. They offer a range of health plans featuring varying levels of coverage and coparticipation options. Amil utilizes both an accredited network and some proprietary facilities to provide services. The company is considered one of the influential "seven sisters of health" in the market. As of March 2024, Amil had 3.16 million beneficiaries. Specific revenue for Amil was not explicitly stated, but the total health plan sector revenue in 2024 was approximately R$ 350 billion.
Rede D'Or Rede D'Or is one of the largest hospital networks in Brazil, primarily focused on providing healthcare services through its extensive chain of hospitals. They are a major player in the hospital segment of the private health market and are also considered one of the "seven sisters of health." Rede D'Or was listed among the largest companies in Brazil by market value in August 2024, reaching R$ 74 billion. Volume estimates, such as the number of patients treated or procedures performed, were not specified in the provided data, although it was noted that Brazil had approximately 3,900 private hospitals in late 2024. Specific revenue figures for 2024 were not explicitly stated.
DASA DASA is a leading company in diagnostic medicine across Brazil and Latin America. Their main services include a comprehensive range of diagnostic tests offered through a wide network of laboratories and diagnostic imaging centers operating under various well-known brands. They are also mentioned as one of the influential "seven sisters of health." The Brazilian diagnostic medicine market performed 2.2 billion exams in 2022. The market had a gross revenue of R$ 40 billion in 2022 and R$ 48.9 billion in 2023. Specific revenue for Dasa in 2024 was not explicitly stated.
LABORATORIO FLEURY (Grupo Fleury) Grupo Fleury is a major player in the diagnostic medicine market, recognized for the quality and breadth of its services, including clinical analyses and diagnostic imaging. They operate through different channels, including Patient Service Units (B2C), Lab to Lab (B2B) services for other laboratories, New Links, and Health Platforms. Grupo Fleury has invested in technology, including artificial intelligence, and completed a business combination with Hermes Pardini in April 2023. In 2024, their B2B segment processed 186 million exams. Their revenue in the last twelve months ending June 2024 was R$ 7.5 billion, with gross revenue of R$ 1.958 billion in the B2B segment in 2024. The overall Brazilian diagnostic medicine market performed 2.2 billion exams in 2022 and had a gross revenue of R$ 40 billion in 2022 and R$ 48.9 billion in 2023. [Abramed] [Moody's Local] [LabNetwork]
Sabin Medicina Diagnóstica Sabin Medicina Diagnóstica is a significant laboratory group with a presence in multiple regions of Brazil. They offer services including clinical analyses, imaging, and vaccination. Sabin has been active in acquisitions since 2019 and recently migrated its units to a single operating system in 2023. Volume and revenue figures specific to Sabin were not provided in the sources, but the broader Brazilian diagnostic medicine market performed 2.2 billion exams in 2022 and had a gross revenue of R$ 40 billion in 2022 and R$ 48.9 billion in 2023. [Abramed]
ONCOCLINICAS DO BRASIL SERVICOS (Oncoclínicas) Oncoclínicas is one of the largest oncology groups in Latin America, specializing in providing services in oncology, hematology, and radiotherapy. They operate through numerous units across Brazil, specifically covering 12 states with 70 units. Specific volume data (e.g., number of patients treated) and revenue figures for 2024 were not explicitly stated in the provided sources.
Comparative Table: Volume, Revenue, and Growth/Decline¶
| Player Name | Main Products/Services | Volume Estimate | Revenue Estimate | Growth/Decline Notes |
|---|---|---|---|---|
| Hapvida NotreDame Intermédica | Health plans, hospital, clinic, and diagnostic services (verticalized). | Over 8.8 million beneficiaries (March 2024). | Not specified for combined entity in 2024. Sector total ~R$ 350 billion (2024). | Health plan sector profits increased 271% in 2024. [Agência Brasil - EBC, 2025/03/18] |
| Grupo NC (includes EMS) | Pharmaceuticals (broad portfolio). | Not specified. (Leads in units sold to pharmacies). | R$ 26.4 billion (sales to pharmacies, 2024). [Abradilan] | N/A |
| Eurofarma | Pharmaceuticals (various therapeutic areas). | Not specified. | Ranked second in sales to pharmacies (2024). Specific value not stated but below R$ 26.4 billion. [Abradilan] | Presented one of the highest increases in revenue in 2024 among major pharmaceutical companies. [Abradilan] |
| Bradesco Saúde | Health insurance plans. | 3.81 million beneficiaries (March 2024). | Not specified for Bradesco Saúde. Sector total ~R$ 350 billion (2024). | Health plan sector profits increased 271% in 2024. [Agência Brasil - EBC, 2025/03/18] |
| AMIL ASSISTENCIA MEDICA (Amil) | Health plan services. | 3.16 million beneficiaries (March 2024). | Not specified for Amil. Sector total ~R$ 350 billion (2024). | Health plan sector profits increased 271% in 2024. [Agência Brasil - EBC, 2025/03/18] |
| Rede D'Or | Hospital services. | Not specified. (Operates a large network of hospitals). | Market value R$ 74 billion (August 2024). Specific revenue not stated. [Blog da Fortes Tecnologia] [Intercept Brasil] | N/A |
| DASA | Diagnostic medicine services (laboratory tests, imaging). | Brazilian market performed 2.2 billion exams (2022). [Abramed] | Brazilian market gross revenue R$ 40 billion (2022) and R$ 48.9 billion (2023). [Abramed] Specific revenue not stated for DASA in 2024. | Brazilian diagnostic medicine market gross revenue increased from R$ 40 billion (2022) to R$ 48.9 billion (2023). [Abramed] |
| LABORATORIO FLEURY (Grupo Fleury) | Diagnostic medicine services (clinical analysis, imaging, B2B services). | 186 million exams processed in B2B segment (2024). [LabNetwork] Brazilian market performed 2.2 billion exams (2022). [Abramed] | R$ 7.5 billion (revenue last 12 months ending June 2024). [Moody's Local] R$ 1.958 billion (B2B gross revenue, 2024). [Moody's Local] Brazilian market gross revenue R$ 40 billion (2022) and R$ 48.9 billion (2023). [Abramed] | B2B revenue of R$ 1.958 billion in 2024. Brazilian diagnostic medicine market gross revenue increased from R$ 40 billion (2022) to R$ 48.9 billion (2023). [Abramed] |
| Sabin Medicina Diagnóstica | Diagnostic medicine services (clinical analysis, imaging, vaccination). | Not specified. Brazilian market performed 2.2 billion exams (2022). [Abramed] | Not specified. Brazilian market gross revenue R$ 40 billion (2022) and R$ 48.9 billion (2023). [Abramed] | Brazilian diagnostic medicine market gross revenue increased from R$ 40 billion (2022) to R$ 48.9 billion (2023). [Abramed] |
| ONCOCLINICAS DO BRASIL SERVICOS | Oncology, hematology, and radiotherapy services. | Operates through 70 units in 12 states. | Not specified. | N/A |
References¶
Abradilan. Dez maiores farmacêuticas do Brasil detêm 48,6% das vendas. https://abradilan.com.br/noticias/dez-maiores-farmaceuticas-do-brasil-detem-486-das-vendas/ BenefíciosRH. 9 Maiores Operadoras de Planos de Saúde para 2025. https://www.beneficiosrh.com.br/plano-de-saude/maiores-operadoras-planos-de-saude/ Agência Brasil - EBC. Lucro de planos de saúde aumentou 271% em 2024. https://agenciabrasil.ebc.com.br/saude/noticia/2025-03/lucro-de-planos-de-saude-aumentou-271-em-2024 Portal Gov.br. ANS divulga dados econômico-financeiros de 2024. https://www.gov.br/ans/pt-br/assuntos/noticias/beneficiarios/ans-divulga-dados-economico-financeiros-de-2024 Intercept Brasil. 'Sete empresas formam oligopólio na saúde privada e controlam a economia nacional', diz pesquisador. https://theintercept.com/2024/08/02/sete-empresas-oligopolio-saude-privada/ Toro Investimentos Blog. Empresas de saúde na Bolsa: quais ações comprar no setor. https://www.toroinvestimentos.com.br/blog/investimentos/empresas-de-saude-na-bolsa Blog da Fortes Tecnologia. As 15 maiores empresas do Brasil em valor de mercado. https://www.fortestecnologia.com.br/blog/maiores-empresas-do-brasil/ LabNetwork. Lab-to Lab Pardini dobra capacidade produtiva de exames e diminui prazo de entrega em 50% no Laboratório Solução em SC. https://labnetwork.com.br/lab-to-lab-pardini-dobra-capacidade-produtiva-de-exames-e-diminui-prazo-de-entrega-em-50-no-laboratorio-solucao-em-sc/ Moody's Local. Fleury S.A. https://moodyslocal.com/wp-content/uploads/2024/09/Relat%C3%B3rio-de-Classifica%C3%A7%C3%A3o-Fleury-S.A.-Set.24-Publica%C3%A7%C3%A3o.pdf Exame. Hora de queimar gordura: como as empresas de saúde cresceram e aumentaram lucros em 2023. https://exame.com/negocios/a-hora-de-queimar-gordura-como-as-empresas-de-saude-cresceram-e-aumentaram-lucros-em-2023/ Abramed. Painel Abramed - O DNA do Diagnóstico (6ª Edição). https://abramed.org.br.storage-arquivo.trendscay.com.br/2024/06/Painel-Abramed-6a-Edicao_atualizado-em-junho_2024.pdf Agência Brasil - EBC. Número de hospitais públicos com UTIs de excelência cresce 45%. https://agenciabrasil.ebc.com.br/saude/noticia/2025-03/numero-de-hospitais-publicos-com-utis-de-excelencia-cresce-45 Noticias R7. Cinco hospitais brasileiros estão entre os 20 melhores da América Latina, aponta pesquisa. https://noticias.r7.com/saude/cinco-hospitais-brasileiros-estao-entre-os-20-melhores-da-america-latina-aponta-pesquisa-13112024